Attached files
file | filename |
---|---|
10-K - FORM 10-K - Bohai Pharmaceuticals Group, Inc. | v324415_10k.htm |
EX-32.1 - EXHIBIT 32.1 - Bohai Pharmaceuticals Group, Inc. | v324415_ex32-1.htm |
EX-31.1 - EXHIBIT 31.1 - Bohai Pharmaceuticals Group, Inc. | v324415_ex31-1.htm |
Exhibit 21.1
Subsidiaries of the Registrant
1. | The Company’s wholly owned subsidiary, Chance High International Limited, a British Virgin Islands company (“Chance High”); |
2. | Chance High’s wholly owned subsidiary, YantaiShencaojishi Pharmaceuticals Co., Ltd., a PRC company (“WFOE”); |
3. | Chance High’s wholly owned subsidiary, YantaiNirui Pharmaceutical Co., Ltd., a PRC company (“WFOE II”); |
4. | the WFOE’s variable interest entity, YantaiBohai Pharmaceuticals Group Co., Ltd., a PRC company (“Bohai”), which is the Company’s initial operating subsidiary; and |
5. | WFOE II’s wholly owned subsidiary, Yantai Tianzheng Pharmaceutical Co., Ltd., a PRC company (“Yantai Tianzheng”), which the Company acquired in August 2011 and is the Company’s second operating subsidiary. |